title: The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
abstract: Oxidative modification of LDL plays an important role in the development of atherosclerosis. High-density lipoprotein (HDL) confers protection against atherosclerosis and the antioxidative properties of paraoxonase 1 (PON1) has been suggested to contribute to this effect of HDL. The PON1 exist in two major polymorphic forms (Q and R), which regulate the concentration and activity of the enzyme and alter its ability to prevent lipid oxidation. However, the association of Q192R polymorphism with PON1's capacity to protect against LDL lipoperoxidation is controversial. The aim of this study was to evaluate the effects of the purified PON1 Q192R and the partially purified HDL-bound PON1 Q192R isoenzymes (HDL-PON1 Q192R) on LDL oxidation, with respect to their arylesterase/homocysteine thiolactonase (HTLase) activities. Cupric ion-induced LDL oxidation was reduced up to 48% by purified PON1 Q192, but only 33% by an equivalent activity of PON1 R192. HDL-PON1 Q192 isoenzyme caused a 65% reduction, whereas HDL-PON1 R192 isoenzyme caused only 46% reduction in copper ion-induced LDL oxidation. These findings reflect the fact that PON1 Q and PON1 R allozymes may have different protective characteristics against LDL oxidation. The protection against LDL oxidation provided by HDL-PON1 Q192R isoenzymes is more prominent than the purified soluble enzymes. Inhibition of the Ca(+2)-dependent PON1 Q192R arylesterase/HTLase by the metal chelator EDTA, did not alter PON1's ability to inhibit LDL oxidation. These studies indicate that the active site involvement of the purified enzyme is not similar to the HDL-bound one, in terms of both PON1 arylesterase/HTLase activity and the protection of LDL from copper ion-induced oxidation. Moreover, PON1's ability to protect LDL from oxidation does not seem to require calcium.
authors: Department of Biochemistry, Faculty of Medicine, Ordu University, Turkey. Electronic address: abayrak@odu.edu.tr.
authors: Ahmet
authors: A
authors: Bayrak
authors: Department of Biochemistry, Faculty of Medicine, Ordu University, Turkey.
authors: Tülin
authors: T
authors: Bayrak
authors: Department of Biochemistry, Faculty of Medicine, Hacettepe University, Turkey.
authors: Ebru
authors: E
authors: Bodur
authors: Department of Biochemistry, Faculty of Medicine, TOBB University of Economics and Technology, Turkey.
authors: Kamer
authors: K
authors: Kılınç
authors: Department of Biochemistry, Faculty of Medicine, TOBB University of Economics and Technology, Turkey.
authors: Ediz
authors: E
authors: Demirpençe
mesh_terms: D043303:Aryldialkylphosphatase / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D002265:Carboxylic Ester Hydrolases / Q000378:metabolism; D003300:Copper / Q000494:pharmacology; D006801:Humans; D007527:Isoenzymes / Q000494:pharmacology; D008075:Lipoproteins, HDL / Q000378:metabolism* / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction; D020641:Polymorphism, Single Nucleotide; D011485:Protein Binding
chemical_list: D007527:Isoenzymes; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D003300:Copper; D002265:Carboxylic Ester Hydrolases; C019734:arylesterase; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human
keywords: High density lipoprotein; Low-density lipoprotein oxidation; PON1 polymorphism; Paraoxonase 1; Purification